Corticosteroid use and bone mineral accretion in children with asthma: effect modification by vitamin D

Sze Man Tse1, H William Kelly, Augusto A Litonjua

  • 1Channing Laboratory, Brigham and Women's Hospital and Harvard Medical School, Boston, MA 02115, USA. reszt@channing.harvard.edu

Insights

Vitamin D insufficiency exacerbates corticosteroid-induced bone loss in boys with asthma. Low vitamin D levels in boys significantly increased the negative impact of oral corticosteroids on bone mineral accretion over time.

Area of Science:

  • Pediatric Endocrinology
  • Respiratory Medicine
  • Bone Metabolism

Background:

  • Corticosteroids negatively impact bone mineral accretion (BMA) in children.
  • Vitamin D insufficiency is common in pediatric populations and linked to reduced bone mineral density (BMD).

Purpose of the Study:

  • To investigate if vitamin D levels influence the adverse effects of corticosteroids on BMD in children with asthma.

Main Methods:

  • Longitudinal study of 780 children (5-12 years) with mild-to-moderate asthma over 4.3 years.
  • Assessed inhaled and oral corticosteroid (OCS) doses, baseline serum 25-hydroxyvitamin D3, and serial BMD via dual-energy x-ray absorptiometry.
  • Calculated annual BMA rates.

Main Results:

  • Baseline vitamin D levels significantly modified the OCS-BMA relationship in boys (P=.023).
  • Vitamin D-insufficient boys showed decreased BMA with increased OCS use (P<.001).
  • Vitamin D-insufficient boys on >2 OCS courses/year had double the BMA decrease compared to unexposed boys.

Conclusions:

  • Vitamin D status is a critical factor in the bone health effects of OCSs in boys with asthma.
  • Further research into vitamin D supplementation for children with poorly controlled asthma is warranted to support bone health.
Abstract

Related Concept Videos

Role of Skin in Vitamin D Synthesis01:23

Role of Skin in Vitamin D Synthesis

The skin plays a crucial role in the synthesis of vitamin D, a vital nutrient for various physiological processes in the body. Vitamin D is unique because it can be synthesized in the skin through a series of chemical reactions triggered by exposure to ultraviolet B (UVB) radiation from sunlight.
The solar UV B rays (290-315 nm) are absorbed by the skin, and 7-dehydrocholesterol (provitamin D3) photolyzes it to previtamin D3, which undergoes a rapid transformation to vitamin D3(cholecalciferol).
Bone Disorders01:29

Bone Disorders

Aging and its effect on bone remodeling is the most common cause of bone disorders. In young and healthy people, bone deposition and resorption happen at an equal rate to maintain optimal bone health.
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
Role of Vitamins in Maintaining Bone Health01:25

Role of Vitamins in Maintaining Bone Health

The growth and maintenance of bone are regulated by a combination of nutritional factors, including vitamins, such as vitamin A, B12, C, D, and K.
Vitamin A
Vitamin A is involved in the process of bone remodeling. Retinoic acid, the active metabolite of Vitamin A, has nuclear receptors in osteoblasts and osteoclasts, which are involved in bone remodeling.
Vitamin B12
Vitamin B12 acts as a cofactor during the formation of osteoblast-related proteins, such as osteocalcin. Vitamin B12 plays a role...
Antiasthma Drugs: Leukotriene Modifiers01:19

Antiasthma Drugs: Leukotriene Modifiers

Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:
Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids01:25

Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids

Inhaled corticosteroids (ICS) are anti-inflammatory drugs used primarily in treating persistent asthma and providing long-term maintenance. They target the bronchial mucosa, the lining of the airways, to control inflammation, a critical factor in asthma progression and exacerbation.
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
COPD: Management Using Bronchodilators and Corticosteroids01:26

COPD: Management Using Bronchodilators and Corticosteroids

Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...